HemOnc Today

👀 ‘Incredibly exciting’ retrospective data from #SABCS25 show #GLP1 receptor agonists may benefit people with #breastcancer. It is ‘prime time’ for well-designed prospective controlled trials, @JasmineSukumar tells @GoHealio. vist.ly/4uich

🎬That’s a wrap on #ELCC in Copenhagen — and what a week it’s been 🥵 @HemOncToday reporters were onsite for every #LungCancer data drop and “this changes things” moment See you next year in #Munich for #ELCC27 ✌️ Missed any of it? We’ve got you 👉bit.ly/4sDckaH

Final day of #ELCC26 — and the coffee is doing some heavy lifting ☕🧠 But don’t check out yet… The last #LungCancer data drops are coming in hot: 🥊 Resistance to targeted therapies 🧬 Bispecific #immunotherapy 🤝 Bold new combos

🤖 #AI scribes can help clinicians see more patients per day, spend more time with them and spend less time documenting. 🎙️ In the future, all administrative work may be “covered by your voice,” Nima Toussi, a medical student @usask told @GoHealio 🔗 bit.ly/4bSzS4f

🫁 New from #ELCC26: #Setidegrasib @AstellasUS shows ‘very promising efficacy’ in advanced #LungCancer, inducing a 35.6% response rate. ‘Manageable’ toxicity may allow the agent to be used in combination or in earlier treatment lines. vist.ly/4wdef

📍#Copenhagen may be little gray at #ELCC26 — steal a moment of “sunshine” before your next data dive If that quick reset turns into a longer wander… don’t worry — we took notes for you 🤓bit.ly/4sDckaH

Day 3⃣ at #ELCC26 — powered by coffee and breaking data ☕️ Today’s buzz: Next-gen #LungCancer therapies, #NSCLC resistance, and how #AI is reshaping care — with data dropping faster than the espresso shots Miss a session? We’re bringing the recap 👉bit.ly/4sDckaH

Roughly 1,500 #BreastCancer survivors showed more than 6⃣0⃣% treated with chemotherapy experienced #neuropathy more than 5⃣ years after treatment. 🎙️ “Patients can have significant, long-lasting side effects,” notes Dr. @shgiordano @UTMDAnderson 🔗 bit.ly/3PqaM5c

#Burnout remains a significant concern among all clinicians, but women have higher rates than men. 📖 Data from @JAMANetworkOpen show interventions that help improve self-care could significantly reduce those discrepancies. vist.ly/4wa9s

🤖 #AI could further personalize care with more accurate of PD-L1 scores #LungCancer. #ELCC26 🗨️ “The overall goal for me as a doctor, and for all doctors, is to be sure that we offer the right treatment to the right patient.” @fred_hirsch @TischCancer vist.ly/4w92n

Catch our fearless @HemOncToday lead @JenniferRSouth1 LIVE at #ELCC26 👀 With the inside track on every session and breaking scoop, she’s the go-to for #LungCancer news. Spotted her between sessions? Flag her down — these insights are the rarest catch! 🙌bit.ly/4sDckaH

🎬 Behind the scenes at #ELCC26 with @GoHealio: Real journalists meet real experts… and catch real coffee-fueled insights☕️ We sat down with the one-and-only @narjustflorezMD @DanaFarberNews @Harvardmed to hear the latest #LungCancer data drops 🫳bit.ly/4sDckaH

🎙️@HemOncToday is reporting LIVE from #ELCC26 in Copenhagen! 🫁 @GoHealio is capturing the game-changing moments and bold ideas set to transform #LungCancer care in 2026 – the year starts here👉 bit.ly/4sDckaH

🌍 Global early-onset #cancer incidence has slightly increased since 1990, but mortality has fallen 1️⃣7️⃣% during the same time. That is “good news,” @rupayan_MD @ClevelandClinic told @GoHealio. ❗ Of concern: Deaths related to #obesity are up 9️⃣3️⃣% vist.ly/4w8ua

Celebrating the leaders, pioneers, and changemakers in medicine. Honor Women’s History Month with today’s WORD DOC, one word at a time! Play now: vist.ly/4w8c6 #WomensHistoryMonth #WomenInMedicine #WORDDOC

Many communities, regions and countries have nurse shortages. 📖Data from @JAMANetworkOpen showed how patients admitted to hospitals without inadequate staffing experience significantly higher in-hospital mortality, readmission rates and lengths of stays. vist.ly/4w5wj

📆 Patients with #BreastCancer can experience #neuropathy more than 5️⃣ years after treatment — especially those who had #chemotherapy, who are at much higher risk. 🗨️ “It’s a lot of patients,” Dr. @shgiordano @UTMDAnderson told @GoHealio. vist.ly/4w5sf

Women with #OvarianCancer frequently experience cancer-related #fatigue. 📱 Data from @JAMANetworkOpen showed use of a self-acupressure app significantly reduced fatigue in this patient population compared with usual care. vist.ly/4w5ny

🆕 #FDA clears combination of Corcept Therapeutics’ #relacorilant ➕ @BMSNews’ #Abraxane for adults with platinum-resistant ovarian, fallopian tube and peritoneal cancers 📊 Combo therapy improves PFS and OS 🆚 Abraxane alone vist.ly/4w5if

The #P53 reactivator #rezatapopt exhibited “impressive” activity in heavily pretreated #OvarianCancer & other solid tumors. 🧪 #BasicScience research turning undruggable targets actionable, per @ShepardDale @ClevelandClinic @CleClinicMD vist.ly/4w4ar

🚨 New findings in @CR_AACR highlight a ‘major mechanism’ for how #obesity increases #cancer risk. 🔎 The insights may help inform early detection and prevention efforts. vist.ly/4vzs4